The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration.

von Achenbach, Caroline; Hevia Hernandez, Giselle; von Gunten, Stephan (2022). The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration. Pharmacology, 107(11-12), pp. 556-563. Karger 10.1159/000527655

[img] Text
Achenbach.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (437kB)

BACKGROUND

Intravenous immunoglobulin and subcutaneous immunoglobulin preparations are used to treat primary and secondary immunodeficiencies, as well as autoimmune and inflammatory conditions.

SUMMARY

For certain indications, only defined formulations or routes of administration are approved by health authorities. However, for other diseases, there are more options, and treatment decisions may be based on different aspects, such as patient conditions and preferences, pharmacokinetics, or pharmacoeconomic considerations.

KEY MESSAGES

Understanding the two different treatment modalities may support the decision-making for the optimal therapeutic option for individual patients. This review summarizes the latest insights into the direct and indirect comparison between the two types of products.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Hevia Hernandez, Giselle, von Gunten, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0031-7012

Publisher:

Karger

Language:

English

Submitter:

Pubmed Import

Date Deposited:

10 Nov 2022 13:56

Last Modified:

06 Dec 2022 00:16

Publisher DOI:

10.1159/000527655

PubMed ID:

36349790

Uncontrolled Keywords:

Autoimmunity Immunodeficiency Intravenous immunoglobulin Subcutaneous immunoglobulin

BORIS DOI:

10.48350/174631

URI:

https://boris.unibe.ch/id/eprint/174631

Actions (login required)

Edit item Edit item
Provide Feedback